Visão selecionada em Inglês
| Descritor em português: | Ligante de CD40 | ||||||
| Descritor em inglês: | CD40 Ligand | ||||||
| Descritor em espanhol: |
Ligando de CD40
| ||||||
| Descritor em francês: | Ligand de CD40 | ||||||
| Termo(s) alternativo(s): |
Antigen, CD154 Antigens, CD154 CD154 Antigen CD154 Antigens CD40L T-B Cell Activating Molecule T-Cell gp39 Antigen TNF Superfamily, Member 5 Tumor Necrosis Factor Ligand Superfamily Member 5 gp39 Antigen, T Cell gp39 Antigen, T-Cell |
||||||
| Código(s) hierárquico(s): |
D12.644.276.374.750.124 D12.776.395.550.185 D12.776.467.374.750.124 D12.776.543.550.198 D23.529.374.750.124 |
||||||
| Identificador Único RDF: | https://id.nlm.nih.gov/mesh/D023201 | ||||||
| Nota de escopo: | A membrane glycoprotein and differentiation antigen expressed on the surface of T-cells that binds to CD40 ANTIGENS on B-LYMPHOCYTES and induces their proliferation. Mutation of the gene for CD40 ligand is a cause of HYPER-IGM IMMUNODEFICIENCY SYNDROME, TYPE 1. |
||||||
| Qualificadores permitidos: |
AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis DE drug effects DF deficiency EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PH physiology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UL ultrastructure UR urine |
||||||
| Número de registro: | 147205-72-9 | ||||||
| Indexação Anterior: |
Membrane Glycoproteins (1992-2000) |
||||||
| Nota MeSH pública: | 2001; CD40 LIGAND was indexed under MEMBRANE GLYCOPROTEINS 1992-2000 |
||||||
| Nota histórica: | 2001(2000) |
||||||
| Veja também os descritores: |
CD40 Antigens
MeSH | ||||||
| Identificador DeCS: | 35344 | ||||||
| ID do descritor: | D023201 | ||||||
| Documentos indexados na Biblioteca Virtual em Saúde (BVS): | Clique aqui para acessar os documentos da BVS | ||||||
| Data de estabelecimento: | 01/01/2001 | ||||||
| Data de entrada: | 23/06/2000 | ||||||
| Data de revisão: | 24/05/2017 |
-
-
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Biological Factors [D23]Biological Factors
|
|
CD40 Ligand
- Conceito preferido
| Identificador do conceito |
M0200619 |
| Nota de escopo | A membrane glycoprotein and differentiation antigen expressed on the surface of T-cells that binds to CD40 ANTIGENS on B-LYMPHOCYTES and induces their proliferation. Mutation of the gene for CD40 ligand is a cause of HYPER-IGM IMMUNODEFICIENCY SYNDROME, TYPE 1. |
| Termo preferido | CD40 Ligand |
| Termo(s) alternativo(s) |
Antigen, CD154 Antigens, CD154 CD154 Antigen CD154 Antigens CD40L T-B Cell Activating Molecule T-Cell gp39 Antigen TNF Superfamily, Member 5 Tumor Necrosis Factor Ligand Superfamily Member 5 gp39 Antigen, T Cell gp39 Antigen, T-Cell |
Queremos a sua opinião sobre o novo sitio web do DeCS/MeSH
Convidamos-lhe a responder a uma pesquisa que não levará mais que 3 minutos
Ir para pesquisa
